相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis
Hanshi Sun et al.
BLOOD (2011)
Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory B-Cell Neoplasms
Beata Holkova et al.
CLINICAL CANCER RESEARCH (2011)
The BH3 α-Helical Mimic BH3-M6 Disrupts Bcl-XL, Bcl-2, and MCL-1 Protein-Protein Interactions with Bax, Bak, Bad, or Bim and Induces Apoptosis in a Bax- and Bim-dependent Manner
Aslamuzzaman Kazi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
Leena Gandhi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
(-)-Gossypol Suppresses the Growth of Human Prostate Cancer Xenografts via Modulating VEGF Signaling-Mediated Angiogenesis
Xiufeng Pang et al.
MOLECULAR CANCER THERAPEUTICS (2011)
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Hiroyuki Inuzuka et al.
NATURE (2011)
Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity
Rupesh Dash et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
Derek Yecies et al.
BLOOD (2010)
Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo
Clint Mitchell et al.
CANCER BIOLOGY & THERAPY (2010)
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies
Paul K. Paik et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells
Jingxuan Pan et al.
CANCER LETTERS (2010)
Actinomycin D Decreases Mcl-1 Expression and Acts Synergistically with ABT-737 against Small Cell Lung Cancer Cell Lines
Haishan Xu et al.
CLINICAL CANCER RESEARCH (2010)
Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma
Jimmy J. Hwang et al.
CLINICAL CANCER RESEARCH (2010)
mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity
Rupesh Dash et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Mcl-1; the molecular regulation of protein function
Luke W. Thomas et al.
FEBS LETTERS (2010)
The Bcl-xL Inhibitor, ABT-737, Efficiently Induces Apoptosis and Suppresses Growth of Hepatoma Cells in Combination with Sorafenib
Hayato Hikita et al.
HEPATOLOGY (2010)
被撤回的出版物: Gossypol Induces Death Receptor-5 through Activation of the ROS-ERK-CHOP Pathway and Sensitizes Colon Cancer Cells to TRAIL (Retracted article. See vol. 291, pg. 16923, 2016)
Bokyung Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma
Wei-Gang Tong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
BI-97C1, an Optically Pure Apogossypol Derivative as Pan-Active Inhibitor of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins
Jun Wei et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Chemotherapeutic drugs sensitize human renal cell carcinoma cells to ABT-737 by a mechanism involving the Noxa-dependent inactivation of Mcl-1 or A1
Henry Zall et al.
MOLECULAR CANCER (2010)
The Pan-Bcl-2 Inhibitor (-)-Gossypol Triggers Autophagic Cell Death in Malignant Glioma
Valerie Voss et al.
MOLECULAR CANCER RESEARCH (2010)
Cisplatin Enhances Protein Kinase R-Like Endoplasmic Reticulum Kinase- and CD95-Dependent Melanoma Differentiation-Associated Gene-7/Interleukin-24-Induced Killing in Ovarian Carcinoma Cells
Adly Yacoub et al.
MOLECULAR PHARMACOLOGY (2010)
Eradication of Therapy-resistant Human Prostate Tumors Using an Ultrasound-guided Site-specific Cancer Terminator Virus Delivery Approach
Adelaide Greco et al.
MOLECULAR THERAPY (2010)
Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant Glioma
Hossein A. Hamed et al.
MOLECULAR THERAPY (2010)
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
Martin Schwickart et al.
NATURE (2010)
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
W. J. Placzek et al.
CELL DEATH & DISEASE (2010)
GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy
N. Heidari et al.
CELL DEATH & DISEASE (2010)
Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia
Rong Chen et al.
BLOOD (2009)
Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24
Luni Emdad et al.
CANCER BIOLOGY & THERAPY (2009)
Mcl-1 is a potential therapeutic target in multiple types of cancer
C. Akgul
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Min H. Kang et al.
CLINICAL CANCER RESEARCH (2009)
Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins
Jun Wei et al.
MOLECULAR CANCER THERAPEUTICS (2009)
RNA Silencing of Mcl-1 Enhances ABT-737-Mediated Apoptosis in Melanoma: Role for a Caspase-8-Dependent Pathway
Angela M. Keuling et al.
PLOS ONE (2009)
Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048)
Shinichi Kitada et al.
BLOOD (2008)
Inducing apoptosis and enhancing chemosensitivity to Gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell
San-Hua Wei et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax)
Marina Konopleva et al.
CANCER RESEARCH (2008)
Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer
Christine L. Hann et al.
CANCER RESEARCH (2008)
Induction of Noxa Sensitizes Human Colorectal Cancer Cells Expressing Mcl-1 to the Small-Molecule Bcl-2/Bcl-XL Inhibitor, ABT-737
Kenji Okumura et al.
CLINICAL CANCER RESEARCH (2008)
A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies
Aaron D. Schimmer et al.
CLINICAL CANCER RESEARCH (2008)
Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa
Yang Meng et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Mimicking the BH3 domain to kill cancer cells
T. Ni Chonghaile et al.
ONCOGENE (2008)
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
K. E. Tagscherer et al.
ONCOGENE (2008)
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas
Kylie D. Mason et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis
Moira Sauane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells
Jiannong Li et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
BCL-2 family proteins: Critical checkpoints of apoptotic cell death
Nika N. Danial
CLINICAL CANCER RESEARCH (2007)
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis
Mai Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The N terminus of the anti-apoptotic BCL-2 homologue MCL-1 regulates its localization and function
Marc Germain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
mir-29 regulates Mcl-1 protein expression and apoptosis
J. L. Mott et al.
ONCOGENE (2007)
The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress
Mohamed Rahmani et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage
Yuting Lin et al.
CELL RESEARCH (2007)
A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma
D. Chauhan et al.
ONCOGENE (2007)
Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma
Liqing Zhuang et al.
MODERN PATHOLOGY (2007)
Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: Down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity
Syed-Rehan A. Hussain et al.
CLINICAL CANCER RESEARCH (2007)
Mechanism and functional role of XIAP and McI-1 down-regulation in flavopiridol/vorinostat antileukemic interactions
Roberto R. Rosato et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia
John C. Byrd et al.
BLOOD (2007)
Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing bak activation and bax translocation
Shuang Chen et al.
CANCER RESEARCH (2007)
Myeloid cell leukemia-1 as a therapeutic target
Arthur M. Mandelin et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia
Marina Konopleva et al.
CANCER CELL (2006)
BIP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis
Pankaj Gupta et al.
CANCER RESEARCH (2006)
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
U Maurer et al.
MOLECULAR CELL (2006)
Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy
W Sieghart et al.
JOURNAL OF HEPATOLOGY (2006)
Unique aspects of mda-7/IL-24 antitumor bystander activity:: establishing a role for secretion of MDA-7/IL-24 protein by normal cells
ZZ Su et al.
ONCOGENE (2005)
Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation
M Rahmani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006
CR Yu et al.
ONCOGENE (2005)
Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death
R Chen et al.
BLOOD (2005)
Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points
KC Bible et al.
CLINICAL CANCER RESEARCH (2005)
Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis
Q Zhong et al.
CELL (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands
CL Day et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Clinical and local biological effects of an intraturnoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study
CC Cunningham et al.
MOLECULAR THERAPY (2005)
Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer
AR Tan et al.
CLINICAL CANCER RESEARCH (2004)
MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol
AM Domina et al.
ONCOGENE (2004)
Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-κB-dependent process
Y Dai et al.
ONCOGENE (2003)
Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model
C Thallinger et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression
JD Khoury et al.
JOURNAL OF PATHOLOGY (2003)
An in vitro study of inhibitory activity of gossypol, a cottonseed extract, in human carcinoma cell lines
M Leblanc et al.
PHARMACOLOGICAL RESEARCH (2002)
Antisense strategy shows that Mcl-1 rather than Bcl-2 or BCI-xL is an essential survival protein of human myeloma cells
S Derenne et al.
BLOOD (2002)
MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes
P Zhou et al.
BLOOD (2001)
Exon skipping in Mcl-1 results in a Bcl-2 homology domain 3 only gene product that promotes cell death
CD Bingle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Apoptosis and cancer chemotherapy
G Makin et al.
CELL AND TISSUE RESEARCH (2000)
分享论文
